Login/Sign Up
CCQ25 Tablet 15's
CCQ25 Tablet is a combination medicine used in the treatment of female infertility. This medicine helps boost the production of hormones involved in the ovulation process. Common side effects include flushing (reddening of the skin, especially the face), headache, Insomnia, tiredness, dizziness, breast pain or tenderness, heavy periods, etc. This medicine is only intended for use in women. Hence, it should not be used in the male population, pregnant/breastfeeding women, and children.
₹726.8*
MRP ₹807.5
10% off
₹686.37*
MRP ₹807.5
15% CB
₹121.13 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
CCQ25 Tablet is an ovulation stimulant medication used to treat infertility in women who are not ovulating (producing an egg) properly or have an irregular or no menstrual cycle. Ovulation issues are a common cause of female infertility.
CCQ25 Tablet is a combination of Clomifene Citrate (oestrogen agonist) and Ubidecarenone (nutritional supplements). Clomifene Citrate boosts the production of hormones involved in the ovulation process. Ubidecarenone is an antioxidant that protects the body from harm caused by chemicals (free radicals) that cause infertility. As a result, CCQ25 Tablet effectively addresses female infertility.
You should take this medicine as prescribed by your doctor. The common side-effects of CCQ25 Tablet are flushing (reddening of the skin, especially the face), headache, Insomnia, tiredness, dizziness, breast pain or tenderness, heavy periods, or bleeding between periods. Tell your doctor if any of these side effects persist or worsen.
Do not take CCQ25 Tablet if you are allergic to Clomifene Citrate or Ubidecarenone or any other ingredients present in it, have liver disease, unexplained and unusual menstrual bleeding, have a type of cancer worse by hormones, or have an ovarian cyst. It is not recommended to use in pregnant women. So, taking a pregnancy test before using this medicine is advised. It is also not recommended for use in children, adolescents, men, and post-menopausal women. Inform your doctor if you are breastfeeding, as this medicine may affect the amount of breast milk produced. Before taking this medicine, let your doctor know if you are taking any other prescription, non-prescription medicines, or herbal products.
CCQ25 Tablet is a combination of Clomifene Citrate (oestrogen agonist) and Ubidecarenone (nutritional supplements). Clomifene Citrate boosts the production of hormones involved in the ovulation process. Ubidecarenone is an antioxidant that protects the body from harm caused by chemicals (free radicals) that cause infertility. Also, Ubidecarenone supplementation results in a better response to ovulation induction and a lower risk of foetal aneuploidy. As a result, CCQ25 Tablet effectively addresses female infertility.
If you are allergic or hypersensitive to Clomifene Citrate, Ubidecarenone, or any other ingredients in CCQ25 Tablet , do not take it. Inform your doctor if you are experiencing early menopause, have been diagnosed as infertile, have stopped menstruating due to being underweight, have previously been diagnosed with fits or seizures (fits), uterine fibroids (non-cancerous tumours in the womb), polycystic ovaries (presence of small cysts on the enlarged ovaries), swollen ovaries, or hypertriglyceridemia (increased fat levels in the body), Before prescribing this medication, your doctor may perform additional tests to rule out other causes of infertility. Because CCQ25 Tablet contains lactose and sucrose, consult your doctor if you are sensitive to sugar. Do not begin taking a new medication without first consulting your doctor. To avoid potential interactions, inform your doctor about any prescription and non-prescription medications you are taking, including other vitamins, before beginning CCQ25 Tablet .
Drug-drug interactions: CCQ25 Tablet may interact with an anti-cancer agent (e.g. bexarotene) and blood thinners (e.g. warfarin, dicumarol, anisindione).
Drug-food interactions: Alcohol may increase the risk of side effects of CCQ25 Tablet .
Drug-disease interactions: CCQ25 Tablet may interact with disease conditions, including abnormal uterine bleeding, liver failure, hyperlipidemia (increased fat levels), uncontrolled adrenal gland dysfunction, thyroid problems and pituitary tumours.
CCQ25 Tablet may cause multiple pregnancies (pregnant with more than one child at the same time) or ectopic pregnancy (growing foetus outside the womb). These conditions may also occur if you are not taking this medicine. However, discuss with your doctor the possible risks before taking CCQ25 Tablet .
Female Infertility: When a woman fails to become pregnant after a year of trying, she is said to have fertility problems. Infertility is also included if a woman becomes pregnant but has miscarriages or stillbirths. The most common cause of infertility is an ovulation problem or uterine damage.
Alcohol
Caution
Alcohol consumption may increase the risk of side effects. Hence, do not consume alcohol while taking CCQ25 Tablet .
Pregnancy
Unsafe
CCQ25 Tablet is a category X drug. It is not recommended to be taken in pregnancy as CCQ25 Tablet may cause birth defects/congenital disabilities in the unborn baby.
Breast Feeding
Caution
CCQ25 Tablet decreases the supply of breast milk. Hence, consult your doctor before taking this medicine if you are breastfeeding.
Driving
Caution
CCQ25 Tablet may cause vision problems, so do not drive or operate heavy machinery after taking CCQ25 Tablet until your vision gets normal.
Liver
Caution
If you have liver problems, be cautious while taking CCQ25 Tablet as this medicine metabolized in the liver. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have kidney problems, be cautious while taking CCQ25 Tablet . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Unsafe
CCQ25 Tablet is not recommended for use in children under 18 years of age.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Customers Also Bought
Product Substitutes